Your browser doesn't support javascript.
loading
Case Report: Two Cases of Soft-Tissue Sarcomas: High TMB as a Potential Predictive Biomarker for Anlotinib Combined With Toripalimab Therapy.
Li, Yong; Liu, Yihong; Qu, Yanchun; Chen, Xian; Qu, Xin; Ye, Yongsong; Du, Xiaohua; Cheng, Ying; Xu, Mian; Zhang, Haibo.
Afiliação
  • Li Y; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Liu Y; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Qu Y; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Chen X; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Qu X; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Ye Y; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Du X; Department of Pathology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Cheng Y; Department of Medical, Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Xu M; Department of Medical, Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Zhang H; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Front Immunol ; 13: 832593, 2022.
Article em En | MEDLINE | ID: mdl-35603147

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Antígeno B7-H1 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Child, preschool / Female / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Antígeno B7-H1 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Child, preschool / Female / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça